Loading
Gestational Diabetes Research and Management · Journal article
Frontiers in Nutrition · September 3, 2026
Raises a question worth testing. It does not answer one.
This mini-review summarizes evidence that maternal dietary fiber and its microbial metabolites (short-chain fatty acids) may program offspring metabolic, immune, and neurodevelopmental health through GPCR and epigenetic mechanisms. The evidence base rests on mechanistic studies, animal models showing protective effects of fiber supplementation and harm from fiber deprivation, and human observational associations, but lacks adequate randomized controlled trials to establish causality or clinical efficacy in humans.
Narrative mini-review. Pregnant women and their offspring, studied via animal models and human observational cohorts; no specific trial population reported.
Maternal fiber deprivation impairs offspring glucose metabolism, promotes low-grade inflammation and obesity, and compromises immune tolerance in animal studies Fiber or SCFA supplementation confers protective effects on offspring metabolic and immune health in animal models Human observational studies show associations between maternal SCFA levels and favorable neonatal metabolic profiles, neurodevelopmental outcomes, and reduced obesity risk
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
While the mechanistic rationale and animal evidence are suggestive, the review explicitly notes that randomized controlled trials in humans remain limited, making it premature to recommend SCFA or fiber interventions as a standard clinical practice during pregnancy beyond general dietary guidance. Clinicians should view this as a research direction requiring further rigorous human trials before adoption.
This is a narrative mini-review synthesizing mechanistic, animal, and observational human evidence without new primary data, raising questions about maternal fiber and SCFA effects on offspring health rather than providing definitive answers.
As stated by the source record.
Quoted from the source exactly as published.
While the mechanistic rationale and animal evidence are suggestive, the review explicitly notes that randomized controlled trials in humans remain limited, making it premature to recommend SCFA or fiber interventions as a standard clinical practice during pregnancy beyond general dietary guidance. Clinicians should view this as a research direction requiring further rigorous human trials before adoption.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Maternal nutrition during pregnancy is a critical determinant of offspring long-term health. Dietary fiber has emerged as a key modifiable factor. Through gut microbial fermentation, fiber is converted into short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate. This mini review synthesizes current evidence from molecular, animal, and human studies on the role of maternal SCFAs in programming offspring metabolic and immune health. Mechanistically, SCFAs act via two complementary pathways: activation of G protein-coupled receptors (GPCRs) and inhibition of histone deacetylases, leading to rapid signaling and long-term epigenetic regulation. Animal studies demonstrate that maternal fiber deprivation impairs offspring glucose metabolism, promotes low-grade inflammation and obesity, and compromises immune tolerance, whereas fiber or short-chain fatty acid (SCFA) supplementation confers protective effects. Human observational studies support these findings, showing associations between maternal SCFA levels and favorable neonatal metabolic profiles, neurodevelopmental outcomes, and reduced obesity risk, although randomized controlled trials remain limited. Key translational challenges include inter-species differences, individual microbiome variability, and optimal intervention timing. Despite these uncertainties, promoting adequate and diverse dietary fiber intake during pregnancy represents a safe, low-cost, and scalable public health strategy to improve intergenerational health outcomes.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.